Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07032818 · ClinicalTrials.gov registry record · NA

Adapted Hospital Discharge Intervention: the CONNECT Pilot

A NA study of Communication Research, sponsored by Boston Medical Center.

Recruiting
Registry status
NA
Development phase
60
Enrollment target
1
Study location

NCT07032818: Recruiting NA study of Communication Research, sponsored by Boston Medical Center.

NCT07032818 is a NA study of Communication Research that is actively recruiting participants, run by Boston Medical Center. The registered enrollment target is 60 participants, below the 494-participant average among 6 other Communication Research trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07032818, a NA study of Communication Research, is actively recruiting participants, sponsored by Boston Medical Center.

RECRUITING
Registry status
NA
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

Hospital discharge is a dangerous time for patients: one in five will suffer an adverse event, such as a medication error, and nearly 25% will be readmitted within 30 days. This time is even more dangerous for patients with who face communication barriers, including those with non-English language preference (NELP), low health literacy, and the elderly. The investigators will pilot a post-discharge educational intervention to reinforce written discharge instructions (known as the After Visit Summary or AVS) using a randomized controlled trial design (2:1 intervention: control). The control group will receive current standard of care discharge education which includes a nurse reviewing their AVS and an automated call in English that allows patients to numerically select types of problems/questions that are then escalated to a nurse who should return their call within a few days. The intervention group will receive the standard of care discharge education with the AVS and an additional post-discharge educational call delivered by a registered nurse or other qualified health professional with the option to have written instructions professionally translated and sent via MyChart message--if available in their preferred language.

Primary Outcome

Number of enrolled participants who completed all study assessments stratified by linguistic group.

Conditions Studied

Interventions

  • OTHER Additional post discharge phone call

Study Locations (1)

Massachusetts

  • Boston Medical Center - Boston

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2026-01-16
Est. Completion 2027-03
Phase NA
Boston Medical Center

253 total trials

What NCT07032818 shows while recruiting

NCT07032818 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 494-participant average among 6 other Communication Research trials with a reported enrollment target (88% lower).

The record links to 1 condition, with Communication Research appearing as the primary indexed condition, and to 1 intervention - of which Additional post discharge phone call is the first listed.

NCT07032818 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT07032818 about?

NCT07032818 is a clinical study titled "Adapted Hospital Discharge Intervention: the CONNECT Pilot". Hospital discharge is a dangerous time for patients: one in five will suffer an adverse event, such as a medication error, and nearly 25% will be readmitted within 30 days. This time is even more dangerous for patients with who face communication barriers, including those with non-English language p...

What is the current status of trial NCT07032818?

This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2026-01-16. Estimated completion is 2027-03.

What conditions does trial NCT07032818 study?

This clinical trial studies the following conditions: Communication Research.

What interventions are being tested in trial NCT07032818?

The interventions under investigation include: Additional post discharge phone call (OTHER).

Who is sponsoring clinical trial NCT07032818?

This trial is sponsored by Boston Medical Center, which has 253 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07032818 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Communication Research

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00576069 · 60 participants

    Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma

  • NCT01297400 · 60 participants · Phase 2

    Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns

  • NCT01734122 · 60 participants

    Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor

  • NCT01804634 · 60 participants · Phase 2

    Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07032818, the US trial registry maintained by the National Library of Medicine. NCT07032818 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.